Joseph Khoury, The University of Texas MD Anderson Cancer Center.. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain 14:15 - 16:00 Session 1: Skin tumors Moderator: Dr
Trang 1Call for platform presentations
We encourage young researchers to participate in the meeting by sending oral presentations
The two best abstracts received will be granted with an economical reward.
Please check the guidelines on the website or kindly contact the technical secretariat for
further information
Deadline for abstract submission: September 15th, 2016
ADVANCES IN PATHOLOGY
AND
MOLECULAR DIAGNOSTICS
in the Era of Personalized Cancer Therap p y
PATHOLOGY MEETING
Meeting Directors
Dr Joseph Khoury
Dr Juan Fernando García García
M a d r i
Target audience
The meeting is aimed at pathologists-in-training, molecular biologists, and medical and
surgical oncologists and surgeons.
Accreditation
Continuing Education Credits requested to the Spanish National Health System
Certification
Venue
Mutua Madrileña Auditorium
Paseo de la Castellana, 33.
Madrid, Spain
Meeting secretariat
Monasterios de Suso y Yuso 34, 4-14-2, 28049 Madrid, Spain
Tel.: +34 91 372 0203 · E-mail: pathologymeeting@doctaforum.com
Under the auspices of
Registrations: www.mdanderson.es/pathologymeeting @MDAnderson_ES
Trang 2Wednesday, October 5th, 2016
13:00 - 14:00 Registration & welcome coffee
14:00 - 14:15 Welcome / Overview
Dr Joseph Khoury, The University of Texas MD Anderson Cancer Center Houston, USA
Dr Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain
14:15 - 16:00 Session 1: Skin tumors
Moderator: Dr Víctor Prieto, The University of Texas MD Anderson Cancer Center Houston, USA
14:15 - 15:00 Aggressive tumors of the skin appendages: Merkel cell carcinoma and other new entities
Dr Víctor Prieto, The University of Texas MD Anderson Cancer Center Houston, USA
15:00 - 15:45 Utility of molecular pathology techniques in the diagnosis of melanoma
Dr José Luis Rodríguez-Peralto, Hospital Universitario 12 de Octubre Madrid, Spain
15:45 - 16:00 Discussion
16:00 - 16:30 Coffee break
16:30 - 17:15 Inaugural lecture
Dr Joxel García, Executive Director, Cancer Control Platform, Moon Shots Operations
The University of Texas MD Anderson Cancer Center Houston, USA
17:15 - 19:00 Session 2: Lung tumors
Moderator: Dr Ignacio Wistuba, The University of Texas MD Anderson Cancer Center Houston, USA
17:15 - 18:00 Molecular pathology of lung cancer - 2016
Dr Ignacio Wistuba, The University of Texas MD Anderson Cancer Center Houston, USA
18:00 - 18:45 Application in Spain of the latest advances in lung cancer
Dr Pilar López-Criado, MD Anderson Cancer Center Madrid, Spain
18:45 - 19:00 Discussion
Thursday, October 6th, 2016
08:30 - 09:30 Keynote lecture
Personalized cancer therapy: Can you MATCH this?
Dr Stanley R Hamilton, The University of Texas MD Anderson Cancer Center Houston, USA
09:30 - 11:15 Session 3: Gastrointestinal tumors
Moderator: Dr Stanley R Hamilton, The University of Texas MD Anderson Cancer Center Houston, USA
09:30 - 10:15 Tumor microenvironment and pancreatic cancer progression
Dr Huamin Wang, The University of Texas MD Anderson Cancer Center Houston, USA
10:15 - 11:00 Molecular pathology of gastric cancer
Dr Fátima Carneiro, Centro Hospitalar de São João Porto, Portugal
11:00 - 11:15 Discussion
11:15 - 11:45 Coffee break
11:45 - 13:30 Session 4: Breast cancer
Moderator: Dr W Frayser Symmans, The University of Texas MD Anderson Cancer Center Houston, USA
11:45 - 12:15 Genomic prediction and breast cancer
Dr W Frayser Symmans, The University of Texas MD Anderson Cancer Center Houston, USA
12:15 - 12:45 New insights into the molecular pathology of lobular breast carcinoma
Dr José Palacios Calvo, Hospital Universitario Ramón y Cajal Madrid, Spain
12:45 - 13:15 Therapeutic impact of molecular pathology in breast cancer: A clinical point of view
Dr Antonio González-Martín, MD Anderson Cancer Center Madrid, Spain
13:15 - 13:30 Discussion
13:30 - 14:30 Lunch
14:30 - 16:15 Session 5: Gynecologic tumors
Moderator: Dr Anais Malpica, The University of Texas MD Anderson Cancer Center Houston, USA
14:30 - 15:00 Ovarian cancer, from molecular pathology to the 2014 WHO classification:
What you need to know
Dr Anais Malpica, The University of Texas MD Anderson Cancer Center Houston, USA
15:00 - 15:30 Integrating molecular pathology in histological typing and prediction of
recurrence in endometrial carcinoma
Dr Xavier Matías-Guiu, Hospital Universitari Arnau de Vilanova Lleida, Spain.
Hospital Universitari de Bellvitge Barcelona, Spain
15:30 - 16:00 Deciphering intratumoral molecular heterogeneity in gynecological cancer
Dr Gema Moreno-Bueno, MD Anderson Cancer Center Madrid, Spain
16:00 - 16:15 Discussion
16:15 - 18:00 Session 6: Sarcoma
Moderator: Dr Gemma Toledo Santana, MD Anderson Cancer Center Madrid, Spain
16:15 - 17:00 From genomics to practical clinical molecular diagnostics in sarcoma:
Where do we stand?
Dr Alexander Lazar, The University of Texas MD Anderson Cancer Center Houston, USA
17:00 - 17:45 Molecular diagnostics and real life in sarcoma signout
Dr Enrique de Álava Casado, Hospital Virgen del Rocío Seville, Spain
17:45 - 18:00 Discussion
18:00 - 18:30 Coffee break
18:30 - 20:00 Session 7: Platform presentations
Moderator: Dr Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain
Case presentations / Platform presentations
Friday, October 7th, 2016 08:30 - 09:30 Plenary lecture
Lymphoproliferative diagnosis: integrated diagnosis paves the way to precision medicine
Dr Miguel Ángel Piris Pinilla, Hospital Universitario Marqués de Valdecilla Santander, Spain
09:30 - 11:30 Session 8: Hematolymphoid tumors
Moderator: Dr L Jeffrey Medeiros, The University of Texas MD Anderson Cancer Center Houston, USA
09:30 - 10:15 Diffuse large B-cell lymphoma
Dr L Jeffrey Medeiros, The University of Texas MD Anderson Cancer Center Houston, USA
10:15 - 10:45 What’s new in T-cell lymphomas and Hodgkin lymphoma
Dr Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain
10:45 - 11:15 New insights into myeloid neoplasms
Dr Joseph Khoury, The University of Texas MD Anderson Cancer Center Houston, USA
10:15 - 11:30 Discussion
11:30 - 12:00 Coffee break
12:00 - 13:45 Session 9: Genitourinary tumors
Moderator: Dr Kanishka Sircar, The University of Texas MD Anderson Cancer Center Houston, USA
12:00 - 12:45 Renal cell carcinoma: A morphologic and molecular understanding of
aggressive and indolent tumors
Dr Kanishka Sircar, The University of Texas MD Anderson Cancer Center Houston, USA
12:45 - 13:30 The evolving landscape of urothelial bladder cancer
Dr Francisco X Real, Spanish National Cancer Research Center (CNIO) Madrid, Spain
13:30 - 13:45 Discussion
13:45 - 15:15 Lunch
15:15 - 17:00 Session 10: Central nervous system tumors
Moderator: Dr Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain
15:15 - 16:00 Molecular classification of brain tumors comes of age: Introducing the 2016 World
Health Organization classification of tumors of the central nervous system
Dr Gregory N Fuller, The University of Texas MD Anderson Cancer Center Houston, USA
16:00 - 16:45 Molecular genetics of gliomas
Dr Bárbara Meléndez Asensio, Hospital Virgen de la Salud Toledo, Spain
16:45 - 17:00 Discussion
17:00 - 17:30 Coffee break
17:30 - 19:00 Session 11: Platform presentations
Moderator: Dr Joseph Khoury, The University of Texas MD Anderson Cancer Center Houston, USA
Case presentations / Platform presentations
19:00 - 19:30 Closing remarks
Dr Joseph Khoury, The University of Texas MD Anderson Cancer Center Houston, USA
Dr Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain